Over half a million people die from cancer every year, according to current statistics. For those diagnosed with pancreatic cancer, the current five-year …
Inventions & Patents
Long-term vision and partnership: UTRF startup to develop next-generation RNA medicines using a novel drug delivery system
Around a decade ago, a researcher at the University of Tennessee Graduate School of Medicine (UTSGM) and a graduate student in her lab began to imagine creating …
UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study, Seeking Emergency Use Authorization from FDA
UT Research Foundation licensee Veru, Inc. announced on April 11, 2022, that their Phase 3 clinical trial of sabizabulin as an oral therapy for hospitalized …